Companies / Actipulse Neuroscience
Actipulse Neuroscience
Cambridge, United States
Actipulse Neuroscience specializes in the research and engineering of Non-Invasive Brain Stimulation technologies for the treatment of psychiatric and neurological disorders.
Actipulse Neuroscience, based in Cambridge, United States, has 2 investors on file, among them StartX and Y Combinator. Its latest round on record is Seed, 1 Jan 2022. Its site was last checked 13 Nov 2026: site answers.
Funding
1 round on recordRound sizes and total raised are on Fundup AI, our sister product for funding data.
Investors
2 investors on file| Investor | Evidence | Type |
|---|---|---|
| Portfolio page | Accelerator | |
| Page + round | Accelerator |
More from StartX
772 companies on its checked portfolioIts portfolio leans to Healthcare & Biotech (25%), AI & Machine Learning (19%), Education (9%).
More from Y Combinator
5,167 companies on its checked portfolioIts portfolio leans to AI & Machine Learning (26%), Fintech (13%), Healthcare & Biotech (11%).
A company is shown only after its own site answers and carries its name. Sites are checked again on a schedule, because domains lapse and get bought. Round stages and dates come from Fundup AI; investor links come from portfolio pages and rounds; other facts name their source when you point at them. How we grade the data
Get Actipulse Neuroscience and its investors as data
Look up any company's investors, or any investor's full portfolio, through one API key or MCP. A free account also opens Ask AI searches and alerts when StartX adds a company.
Work email, sign-in link by email. Already have an account? Log in- Ask AI5 plain-English investor searches a day
- Full listsEvery portfolio row and two-firm overlap
- API and MCP100 REST or MCP calls a month, one key
- AlertsFollow 5 investors for portfolio and fund changes
$ curl -H "X-API-Key: YOUR_KEY" \
https://api.vcinfo.io/v1/companies/actipulseneuroscience.com/investors
# also
GET /v1/companies/actipulseneuroscience.com
GET /v1/companies/actipulseneuroscience.com/news